June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Retinoic acid signaling maintains the blood-retinal barrier through potential crosstalk with the mTOR pathway
Author Affiliations & Notes
  • Lana Pollock
    Ophthalmic Research, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Jing Xie
    Ophthalmic Research, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Brent A. Bell
    Ophthalmic Research, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Bela Anand-Apte
    Ophthalmic Research, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
    Department of Cell Biology, Cleveland Clinic Lerner College of Medicine at CWRU, Ohio, United States
  • Footnotes
    Commercial Relationships   Lana Pollock, None; Jing Xie, None; Brent Bell, None; Bela Anand-Apte, None
  • Footnotes
    Support  NIH grants EY016490, EY015638, EY026181, F32EY029147, T32EY024236, P30EY025585, a Research to Prevent Blindness Challenge Grant; Foundation Fighting Blindness Center Grant
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2368. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lana Pollock, Jing Xie, Brent A. Bell, Bela Anand-Apte; Retinoic acid signaling maintains the blood-retinal barrier through potential crosstalk with the mTOR pathway. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2368.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The blood-retinal barrier (BRB) mediates movement of molecules from the blood to the inner retina, protecting the retinal neural tissue from potentially harmful molecules and maintaining retinal homeostasis. We have previously demonstrated that retinoic acid (RA) signaling is necessary for integrity of the blood-retinal barrier (BRB). The purpose of this study was to investigate the molecular mechanisms by which RA maintains the BRB.

Methods : To visualize the BRB in vivo, we utilized the transgenic Tg(l-fabp:DBP-EGFP) zebrafish model that expresses vitamin D binding protein (a member of the albumin gene family) tagged to GFP. This model displays the integrity of the BRB with GFP-tagged protein localized within the retinal vasculature by 3 days post-fertilization. Breakdown of the BRB is visualized as “leaking” of GFP outside the vasculature. To disrupt RA signaling, transgenic embryos and adults were treated with varying concentrations of DEAB and BMS493, antagonists of retinal dehydrogenase and the RA receptor, respectively. Leakage from the retinal vasculature was visualized under a fluorescent microscope. To identify molecular pathways that potentially regulate RA-mediated BRB maintenance, we conducted RNA-seq comparing gene expression in retinas of adult DEAB-treated zebrafish with control (DMSO)-treated fish.

Results : Treatment with DEAB or BMS493 resulted in a non-functional disrupted BRB in up to 95% of embryos and adults. Co-treatment with 0.05 µM all-trans retinoic acid effectively rescued BRB integrity. Pathway analysis of differentially expressed genes indicated that the mTOR pathway is significantly upregulated in retinas of DEAB-treated fish. Inhibition of mTOR signaling in BMS493 or DEAB-treated larvae by co-treatment with rapamycin prevented BRB breakdown.

Conclusions : The mTOR signaling pathway is significantly upregulated in the retinas of RA-inhibitor-treated fish and inhibition of mTOR signaling prevents RA-inhibitor-mediated BRB breakdown. Thus, RA signaling may maintain BRB integrity via crosstalk with the mTOR pathway.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×